As blockbuster drugs fizzle, biotech looks to the next big thing https://t.co/s6AWLwYJS5
— The Propell Group (@ThePropellGroup) May 5, 2017
#healthtech
As blockbuster drugs fizzle, biotech looks to the next big thing https://t.co/s6AWLwYJS5
— The Propell Group (@ThePropellGroup) May 5, 2017
#healthtech